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rTo the Editor: Early percutaneous coronary intervention (PCI) and
reperfusion of obstructed epicardial arteries have improved patient
survival after myocardial infarction (MI), but downstream, microvas-
cular obstruction (MVO) remains a significant negative predictor after
acute infarct PCI (1). Recently, it has been suggested that dynamic
contrast-enhanced multidetector computed tomography (MDCT)
may be equally effective as magnetic resonance imaging (MRI) in
predicting MVO in the clinical setting (2), but evidence validating
his contention is scant. Nitrite ions are microvascular vasodilators,
nd have been demonstrated to reduce MRI-defined MVO, and to
mprove endocardial blood flow in a large-animal MI model, verified
sing the accepted gold standard: thioflavin S exclusion (TSE) to
efineMVO andmicrosphere analysis to measure regional blood flow
RBF) (3).
The purpose of this study was: 1) to correlate putative MVO contrast
ttenuation patterns (hypoenhancement area on MDCT image) with
VO derived from ex vivo TSE and RBF assessment; and 2) to
etermine whether nitrite-induced dynamic changes in MVO could be
qually detected using RBF assessment and MDCT image analysis.
Sixteen female, 25 kg to 30 kg, Landrace pigs (of which 12
urvived: 6 in the saline group; 6 in the nitrite group) underwent
xperimental MI by balloon occlusion of the mid left anterior
escending artery for 90 min followed by reperfusion for 2 h (4). After
alloon deflation, MDCT and microsphere delivery were performed at
he same time point. Areas of hyperenhancement and hypoenhancement
ere determined using a 5-min delayed enhancement scan. The number
f microspheres detected in each region of the heart, corrected for aortic
lood flow, provided RBF for that region for each condition (5). Nitrite
iluted in saline (0.2 mol · min1 · kg1), or an equal volume of saline,
was delivered in the mid left anterior descending artery at the onset of
reperfusion. Twenty-four hours after MI, animals underwent repeat
MDCT and microspheres administration. An injection of 20 ml 4%
thioflavin S was made into the left ventricle (LV) 2 min before
sacrifice. The heart was then explanted and sliced into short-axis slices
1 cm thick. A 2,3,5-triphenyltetrazolium chloride (TTC)-2% solution
was used to delineate the infarct area.
The TTC- and TSE-defined regions for microspheres sampling
identified distinct differences in RBF between remote, TTC-defined
infarct, and TSE-definedMVO areas 24 h afterMI at basal, mid, and
apical ventricular levels: infarct and MVO areas had significantly
reduced RBF (Fig. 1A and 1B), validating TTC- and TSE-defined
areas. Microspheres analysis also showed a significant increase in RBF
in remote and MVO (p  0.05) regions in the nitrite-treated group
compared with the saline-treated group (n  6 pigs per group)
(Figs. 1A and 1C), confirming nitrite beneficial effects on MVO after
MI. Combined hypoenhancement and hyperenhancement areas on
MDCT (putative infarct zone) correlated well with TTC-defined
infarct area (r2  0.74, n  12 pigs, p  0.004) (Figs. 1A and 1D).owever, MDCT hypoenhancement (putative MVO area) did not
orrelate well with TSE-defined MVO area (r2  0.42, n  9 pigs,
p 0.21) (Figs. 1A and 1E). The MDCT imaging analysis after MI
did not show any significant difference between saline- and nitrite-
treated groups in terms of percent changes in infarct size (combined
hypoenhancement and hyperenhancement/LV: 15.6  6.9% and
10.0  15.7%, respectively; p  0.76) or hyperenhancement/LV
atio (43.1  36.4% and 27.3  36%, respectively; p  0.77) and
hypoenhancement/LV ratio (38.7  15.9% and 46.0  18.5%,
respectively; p  0.78; n  6 pigs per group) (Fig. 1F).
This study demonstrates that MDCT hypoenhancement area after
MI does not accurately predict MVO area, suggesting limitations of
MDCT for the detection of MVO. Thus, reduced RBF (impairing
contrast penetration) may not be the only determinant of hypoen-
hancement on MDCT. Moreover, in this study, MDCT did not
predict dynamic changes in MVO, suggesting that, as well as not
being a good imaging modality to detect MVO changes after
therapeutic intervention, it may also be suboptimal in detecting
dynamic MVO responses to vasodilators. Our data do, however,
confirm prior suggestions that combined hypoenhancement and
hyperenhancement area on MDCT is a reliable measure of infarct
area. In terms of imaging infarction, a significant advantage of
MDCT over MRI is that signal density values are unique and
determined by the physical properties of individual constituents of the
heart resulting from direct attenuation of X-rays by iodine molecules,
not an indirect measure resulting from gadolinium-induced altera-
tions of water proton relativity, as on MRI. Therefore, MDCT may
be, hypothetically at least, a more accurate modality for measuring
infarct size. Our data have clinical implications, suggesting caution
when using CT to detect MVO in post-MI patients.
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Figure 1 Multidetector CT and MVO Definition 24 H After MI
(A) Representative 2,3,5-triphenyltetrazolium chloride (TTC)-stained heart section
nation (microvascular obstruction [MVO] delineated in red), and multidetector com
hancement area (black contour), and hypoenhancement area (red contour). (B) I
infarct (shaded bars), and TSE-defined MVO areas (solid bars), regional blood flow
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Letters to the Editor
Hypertrophic Cardiomyopathy
in Childhood
The Gradient Is Not the Disease.
Excessive Use of Experimental
Invasive Interventions
We read with much interest the study of Sreeram et al. (1) from
ermany and United Kingdom in which the authors used the
ovel strategy of radiofrequency ablation of the ventricular septum
o produce intramuscular scars and reduce outflow tract obstruc-
ion in young children with hypertrophic cardiomyopathy (HCM).
he study population is unique for HCM: 1) sizable for this age
roup (mean age: 10 years, with children as young as 2 years [n  2]
nd with 25% 6 years of age or younger); 2) symptoms attributed
o HCM although seemingly very modest (i.e., tiredness in 28
atients), with some being virtually asymptomatic; and 3) lacking
etailed information about preablation pharmacologic therapy and
o consideration for surgery.
Subaortic gradients historically have been the most visible
omponent of HCM, almost by reflex triggering concern, which is
ften disproportionate to hemodynamic significance (2). Notably,
he authors aggressively promoted invasive intervention to reduce
utflow obstruction in very young patients, using an experimental
echnique that will undoubtedly prove controversial. Radiofre-
uency ablation sufficient to reduce septal thickness strikes us as
ounterintuitive, a concern which is compounded by the authors’
ailure to report septal thickness before or after ablation.
Experimentation on children with HCM has been an unfortu-
ate part of the disease history (3). Therefore, we take this
pportunity to underscore the acknowledged principle that outflow
radients in HCM do not always represent a disease feature that
equires immediate action and abolition. Although left ventricular
utflow obstruction is a determinant of progressive heart failure in
CM (4), many patients of all ages tolerate gradients for long
eriods without surgical or other major interventions. Furthermore,gradient-related symptoms can be controlled pharmacologically
(5), including disopyramide, which is capable of reducing outflow
obstruction (6).
It is rarely (if ever) necessary to invasively remove gradients
prophylactically in the absence of severe symptoms, particularly in
young patients. This tenet is supported by the American College of
Cardiology (4,7), the American Heart Association (7), and the
European Society of Cardiology (4) consensus recommendations
and guidelines (2003 and 2011). Over the course of almost 10
years, these societies have agreed that invasive intervention to
remove outflow obstruction in HCM should be reserved for
patients with disabling heart failure symptoms. Tiredness, as
reported by Sreeram et al. (1), is difficult to interpret in HCM
patients of any age (and particularly in young children), may not be
the consequence of outflow obstruction, and is not an indication
for invasive intervention.
Indeed, one of the major concerns with prematurely undertak-
ing invasive gradient reduction in young HCM patients is under-
scored by the outcome data reported in this small cohort (n  32):
2 deaths (1 procedural death [age: 4 years] and 1 sudden death), 1
patient each with a permanent pacemaker for heart block, implant-
able defibrillator, or failure to experience symptom improvement;
and 2 patients with ventricular fibrillation, one of whom had mitral
valve replacement and myectomy at age 5 years. The adverse
consequence rate was 22%.
It is important to underscore that HCM is a complex disease,
and although outflow obstruction can be an important determinant
of clinical course, a subaortic gradient in a young patient should
not be regarded as if it were the disease itself, necessitating invasive
therapy without regard to the potential consequences.
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